Evaluation and intervention for ADHD and language disorders in children

Early Clinical Evaluation and Intervention of Developmental Behavioral Diseases Based on Multicenter Cohort Study

This study is trying to find better ways to diagnose and treat language disorders and ADHD in children by following a large group of kids over two years.

Quick facts

• Phase: NA
• Study type: Interventional
• Enrollment: 2100 (estimated)
• Ages: 1 Year to 6 Years
• Sex: All
• Sponsor: Children's Hospital of Chongqing Medical University (other)
• Locations: 1 site (Chongqing, Chongqing)
• Trial ID: NCT06025890 on ClinicalTrials.gov

What this trial studies

This study aims to establish a multi-center cohort in China for the early diagnosis of language disorders and ADHD in children. It will develop assessment tools and intervention programs based on a cohort of 900 children with language disorders and 1,200 children with ADHD, following them over a two-year period. The study will utilize professional assessments, blood sample collection, and fNIRS task tests to gather data and formulate standardized intervention plans. The results will be extended to 50 hospitals to improve early diagnosis and treatment.

Who should consider this trial

Good fit: Ideal candidates for this study are children aged 1-6 years who are being evaluated for language disorders or ADHD.

Not a fit: Patients with a history of language development delay, previous intervention treatment, or other significant neurological or developmental disorders may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to improved early diagnosis and intervention for children with ADHD and language disorders, enhancing their developmental outcomes.

How similar studies have performed: Other studies have shown success with similar approaches in early diagnosis and intervention for developmental disorders, indicating a promising avenue for this research.

Eligibility criteria

1. Language disorder

Inclusion criteria:

1. Language disorder(n=900): This study included children between the ages of 1-4 who were evaluated for potential language disorder by two developmental behavioral specialists holding the title of associate professor or higher.
2. Control group(n=100): This study included children between the ages of 1-4 who were exclude with language disorder by two developmental behavioral specialists with the title of associate professor or higher.

Exclusion criteria:

1. Children with a history of language development delay or language disorder intervention treatment.
2. DQ score below 85.
3. (3) Patients with organic diseases of the nervous system, epilepsy, autism spectrum disorder, global developmental delay, and hearing impairment, and/or people caring for patients with mental illness, hearing impairment,language disoeder.

2.ADHD

Inclusion criteria:

1. ADHD(n=1200): This study included children between the ages of 3-6 who were evaluated for potential ADHD by two developmental behavioral and/or psychiatrists with the rank of associate professor or higher.
2. Control group(n=100):This study included children between the ages of 1-4 who were exclude with ADHD by two developmental behavioral and/or psychiatrists with the rank of associate professor or higher.

Exclusion criteria:

1. Children with ADHD intervention treatment.
2. DQ score lower than 85, or IQ score lower than 80.
3. Patients with organic diseases of the nervous system, epilepsy, autism spectrum disorder, global developmental delay, mental retardation, atopic dermatitis, asthma, hearing impairment or visual impairment.

Where this trial is running

Chongqing, Chongqing

• Growth, Development and Mental health of Children and Adolescence Center — Chongqing, Chongqing, China (RECRUITING)

Study contacts

• Study coordinator: Li Chen, doctor

Conditions: ADHD, Language Disorders, Language Disorder, Artificial Intelligence, fNIRS